Novocure Announces Preliminary Full Year and Fourth Quarter 2025 Performance and Provides Company Update
Novocure to Present New Research for Tumor Treating Fields Therapy at European Association of Neuro-Oncology Meeting and the European Society for Medical Oncology Congress
Novocure to Present Final Results from the Pivotal Phase 3 METIS Trial of its Tumor Treating Fields Therapy for Brain Metastases from Non-Small Cell Lung Cancer at 2025 ASTRO Annual Meeting
Novocure's Optune Lua® Receives Approval in Japan for the Treatment of Unresectable Advanced/Recurrent Non-Small Cell Lung Cancer
Novocure Announces Coverage of Tumor Treating Fields Therapy for Patients with Newly Diagnosed Glioblastoma in Spain
Novocure Submits Premarket Approval Application to FDA for Tumor Treating Fields Therapy in Locally Advanced Pancreatic Cancer
African Discovery Group announces signing of Definitive Sales and Purchase Agreement for Butembo Copper Asset in the Democratic Republic of Congo; name change to Copper Intelligence, Inc
Saga Metals Acknowledges U.S. Strategic Critical Minerals Reserve "Project Vault" and Highlights Titanium's Strategic Importance to North American Defense Supply Chains
Blackrock Silver to Present at the Precious Metals and Critical Minerals Virtual Investor Conference on February 10th 2026
